IFNG and melanoma: The combination of TNF-α, IFN-γ and melphalan in an isolated limb perfusion setting shows impressive remission rates in irresectable soft tissue sarcomas [32] and melanoma [33] and remains a possible treatment option for advanced disease [34, 35].